These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 42304)

  • 1. The effect of immunization on polymorphonuclear leukocyte chemotaxis in influenza.
    Baum J; Douglas RG
    Acta Virol; 1979 Sep; 23(5):433-6. PubMed ID: 42304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired polymorphonuclear leucocyte chemotaxis after influenza virus infection.
    Larson HE; Parry RP; Tyrrell DA
    Br J Dis Chest; 1980 Jan; 74(1):56-62. PubMed ID: 7356914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza virus split vaccines. Effect of priming infection on serologic response in humans.
    Niculescu IT; Zilisteanu E; Cretescu L; Matepiuc M; Dumitrescu R; Oprescu E; Bodnar C; Cuteanu I; Vlad A; Mogos A
    Arch Roum Pathol Exp Microbiol; 1979; 38(2):147-54. PubMed ID: 262510
    [No Abstract]   [Full Text] [Related]  

  • 5. Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigens.
    Mackenzie JS; Wetherall JD; Fimmel PJ; Hawkins BR; Dawkins RL
    Dev Biol Stand; 1977 Jun 1-3; 39():355-62. PubMed ID: 604120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
    Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
    Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 9. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies in influenza vaccines].
    Kunz C; Wiedermann G; Dostal V
    Wien Med Wochenschr; 1975 Oct; 125(40):581-2. PubMed ID: 1226778
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
    Mbawuike IN; Piedra PA; Cate TR; Couch RB
    J Med Virol; 1996 Oct; 50(2):105-11. PubMed ID: 8915874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of infection with influenza virus on the function of polymorphonuclear leukocytes.
    Martin RR; Couch RB; Greenberg SB; Cate TR; Warr GA
    J Infect Dis; 1981 Sep; 144(3):279-80. PubMed ID: 7276637
    [No Abstract]   [Full Text] [Related]  

  • 13. Serologic response of gilts of breeding age to human influenza vaccines containing A/New Jersey/76 (HSW1N1) antigen.
    Woods GT; Mansfield ME
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):177-80. PubMed ID: 625589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of influenza vaccination on pulmonary function.
    Dull WL; Seria J; Bloomfield J; Secker-Walker RH; Ayres SM
    Bull Eur Physiopathol Respir; 1980; 16(5):655-61. PubMed ID: 7417724
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of the reproductive and immunogenic activity of moderately attenuated influenza A/1977-1980 viruses].
    Zhilova GP; Ermolaeva OM; Orlov VA
    Tr Inst Im Pastera; 1982; 58():25-30. PubMed ID: 7187550
    [No Abstract]   [Full Text] [Related]  

  • 17. [Low protection against this winter's influenza. A repeat performance of last season's subtype A?].
    Grandien M; Nordén A; Jonson G
    Lakartidningen; 1992 Dec; 89(50):4374. PubMed ID: 1469973
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiological investigations in young children's communities concerning the efficiency of prophylactic immunization with inactivated influenza vaccine (I.C. 80) in a preepidemic season.
    Măgureanu E; Busuioc C; Ionescu V; Tisu A; Coban V; Stoicescu A; Guguianu E; Calomfirescu N; Bordeianu V; Toma C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):233-8. PubMed ID: 7159214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preventive influenza vaccination].
    Glathe H
    Z Arztl Fortbild (Jena); 1990; 84(8):377-80. PubMed ID: 2378120
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.